ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,440Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 107

$544K Total Retail Price of All Prescriptions

Rank: 28 out of 107

328 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 328 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

4% of this provider’s 328 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 10,860 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 481 410 1 8
FUROSEMIDE 445 441 2 3
CITALOPRAM HBR 377 375 3 9
LISINOPRIL 364 364 4 4
OMEPRAZOLE 356 324 5 6
DONEPEZIL HCL 309 309 6 10
AMLODIPINE BESYLATE 306 289 7 5
LEVOTHYROXINE SODIUM 291 279 8 1
TRAZODONE HCL 248 248 9 22
MIRTAZAPINE 235 235 10 16
SIMVASTATIN 235 235 10 2
DIVALPROEX SODIUM 208 190 12 55
NAMENDA 200 200 13 19
TRAMADOL HCL 197 194 14 23
METOPROLOL TARTRATE 188 188 15 7
GABAPENTIN 171 150 16 11
ATENOLOL 169 163 17 21
LANTUS 166 166 18 34
SERTRALINE HCL 164 164 19 12
METOPROLOL SUCCINATE 156 156 20 15
ALENDRONATE SODIUM 132 132 21 35
ATORVASTATIN CALCIUM 129 119 22 17
PANTOPRAZOLE SODIUM 120 113 23 28
DIGOXIN 110 106 24 37
ALBUTEROL SULFATE 100 52 25 67
RISPERIDONE 98 85 26 26
BUSPIRONE HCL 96 82 27 82
HYDROCHLOROTHIAZIDE 96 96 27 14
NOVOLOG 96 96 27 76
KLOR-CON M10 94 94 30 97
PREDNISONE 93 68 31 39
QUETIAPINE FUMARATE 92 92 32 31
ESCITALOPRAM OXALATE 88 88 33 40
POLYETHYLENE GLYCOL 3350 87 87 34 24
RANITIDINE HCL 86 86 35 41
NYSTATIN 85 82 36 116
IPRATROPIUM-ALBUTEROL 85 77 36 49
METFORMIN HCL 85 85 36 13
DIOVAN 83 83 39 33
SPIRIVA 82 70 40 69
KLOR-CON M20 78 74 41 45
ISOSORBIDE MONONITRATE ER 73 73 42 30
SEROQUEL 68 68 43 87
VENLAFAXINE HCL ER 67 67 44 75
CLOPIDOGREL 66 66 45 29
HYDROCODONE-ACETAMINOPHEN 64 64 S3 46 20
SPIRONOLACTONE 63 44 47 74
TAMSULOSIN HCL 61 61 48 27
ADVAIR DISKUS 59 46 49 47
FLUTICASONE PROPIONATE 57 44 50 54
OLANZAPINE 56 42 51 57
AMIODARONE HCL 54 54 52 93
TAMIFLU 53 51 53 315
FLUOXETINE HCL 52 40 54 102
TRIAMCINOLONE ACETONIDE 52 50 54 196
CARVEDILOL 52 52 54 25
POTASSIUM CHLORIDE 51 51 57 18
PLAVIX 51 51 57 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 31, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.